ВЛИЯНИЕ КИШЕЧНОЙ МИКРОФЛОРЫ НА МЕТАБОЛИЗМ ЭСТРОГЕНОВ И РАЗВИТИЕ ДИСГОРМОНАЛЬНЫХ ГИНЕКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ

DOI: https://doi.org/10.29296/25877305-2019-01-02
Скачать статью в PDF
Номер журнала: 
1
Год издания: 
2019

А. Сорокина, доктор медицинских наук Клиника «IQ Health», Москва E-mail: anna_sorokina77@mail.ru

Одной из ведущих причин дисгормональных гинекологических заболеваний (ДГЗ) является накопление в организме токсинов и тяжелых металлов, оказывающих гормоноподобное действие и приводящих к гиперэстрогении вследствие образования вредных метаболитов эстрогенов. В этих процессах непосредственное участие принимает микрофлора кишечника, а именно – ее дисбаланс с преобладанием грибковой и другой условно-патогенной микрофлоры. В связи с этим патогенетически обоснованным лечением ДГЗ следует считать коррекцию микрофлоры кишечника, снижение повышенной проницаемости его стенки и общую детоксикацию организма.
Ключевые слова: 
гастроэнтерология
акушерство и гинекология
кишечная микрофлора
метаболиты эстрогенов
гинекологические заболевания
Для цитирования
Сорокина А. ВЛИЯНИЕ КИШЕЧНОЙ МИКРОФЛОРЫ НА МЕТАБОЛИЗМ ЭСТРОГЕНОВ И РАЗВИТИЕ ДИСГОРМОНАЛЬНЫХ ГИНЕКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ . Врач, 2019; (1): 9-15 https://doi.org/10.29296/25877305-2019-01-02

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

Список литературы: 
  1. Muti P., Bradlow H. et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 16alphahydroxyestrone ratio in premenopausal and postmenopausal women // Epidemiology. – 2000; 11 (6): 635–40.
  2. Rogan E, Badawi A. et al. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer // Carcinogenesis (England). – 2003; 24 (4): 697–702.
  3. Liehr J., Ricci M. 4-Hydroxylation of estrogens as marker of human mammary tumors // Proc. Natl. Acad. Sci. USA. – 1996; 93 (8): 3294–6.
  4. Utsunomiya H., Ito K. et al. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma // Clin. Cancer Res. – 2004; 10 (17): 5850–6.
  5. Guillemette C., Belanger A., Lepine J. Metabolic inactivation of estrogens in breast tissue by UDP- glucuronosyltransferase enzymes: an overview // Breast Cancer Res. – 2004; 6 (6): 246–54.
  6. Bradlow H., Davis D. et al. Effects of pesticides on the ratio of 16/2-hydroxyestrone: a biologic marker of breast cancer risk // Environ Health Perspect. – 1995; 103 (suppl. 7): 147–50.
  7. Toba T., Shidoji Y. et al. Growth suppression and induction of heatshock protein-70 by 9-cis beta-carotene in cervical dysplasiaderived cells // Life Sci. (England). – 1997; 61 (8): 839–45.
  8. Nagata C., Shimizu H. et al. Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan // Br. J. Cancer (Scotland). – 1999; 81 (7): 1234–7.
  9. Lou H., Wu R., Fu Y. Relation between selenium and cancer of uterine cervix // Zhonghua Zhong Liu Za. – 1995; 17 (2): 112–4.
  10. Kaaks R. Nutrition, hormones, and breast cancer: Is insulin the missing link? // Cancer Causes Control. – 1996; 7: 605–25.
  11. Musey P., Collins D., Bradlow H. et al. Effect of diet on oxidation of 17 β-estradiol in vivo // J. Clin. Endocrinol. Metab. – 1987; 65 (4): 792–5.
  12. Bradlow H., Davis D., Lin G. et al. Effects of pesticides on the ratio of 16α/2- hydroxyestrone: a biological marker of breast cancer risk // Environ Health Perspect. – 1995; 103 (Suppl. 7): 147–50.
  13. Ioannides C. Effect of diet and nutrition on the expression of cytochromes P450 // Xenobiotica. – 1999; 29 (2): 109–54.
  14. Shultz T., Howie B. In vitro binding of steroid hormone by natural and purified fibers // Nutr. Cancer. – 1986; 8 (2): 141–7.
  15. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations // Scand. J. Clin. Lab. Invest. – 1990; 50 (S201): 3–23.
  16. Adlercreutz H., Hockerstedt K., Bannwart C. et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolites of estrogens and in sex hormones bindingglobulin (SHBP) // J. Steroid Biochem. – 1987; 27 (4–6): 1135–44.
  17. Turnbaugh P., Backhed F. et al. Diet-indused obesity is linked to marked but reversible alterations in the mouse distal gut microbiome // Cell Host Microbe. – 2008; 3: 213–23.
  18. Tremellen K., Syedi N. et al. Metabolic endotoxaemia – a potential novel link between ovarian inflammation and impaired progesterone production // Gynecol. Endocrinol. – 2015; 31 (4): 309–12. DOI: 10.3109/09513590.2014.994602.
  19. Hildebrandt M., Hoffmann C. et al. Hight-fat diet determines the composition of the murine gut microbiome independently of obesity // Gastroenterology. – 2009; 137: 1716–24.
  20. Tomer Y. et al. Infection, Thyroid disease and autoimmunity // Endocr. Rev. – 1993; 14 (1): 107–20.
  21. Petru G., Stünzner D., Lind P. et al. Antibodies to Yersinia enterocolitica in immunogenic thyroid disease // Acta Med. Austriaca. – 1987; 14 (1): 11–4.
  22. Kadooka Y., Sato M. et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial // Eur. J. Clin. Nutr. – 2010; 64: 636–43.
  23. Wang C., Makela T. et al. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes // J. Steroid Biochem. Molec. Biol. – 1994; 50: 205–12.
  24. Xu X., Duncan A. et al. Effect of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women // Cancer Epidemiol. Biomarkers Prev. – 1998; 7 (12): 1101–8.
  25. Xu X., Duncan A. et al. Soy consumption alters endogenous estrogen metabolism in postmenopausal women // Cancer Epidemiol. Biomarkers Prev. – 2000; 9 (8): 781–6.
  26. Bolton J., Pisha E. et al. Role of quinoids in estrogen carcinogenesis // Chem. Res. Toxicol. – 1998; 11: 1113–27.
  27. Michnovicz J., Adlercreutz H. Changes in levels of urinary estrogen metabolites after oral indol-3-carbinol treatment in humans // J. Natl. Cancer Inst. – 1997; 89 (10): 718–23.
  28. Tiwari R., Guo L., Bradlow H. et al. Selective responsiveness of human breast cancer cells to indol-3-carbinol, a chemopreventive agent // J. Natl. Cancer Inst. – 1994; 86 (2): 126–31.
  29. Riby J., Feng C. et al. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway // Biochemistry (United States). – 2000; 39 (5): 910–8.
  30. Bradlow H., Sepkovic D. et al. Multifunctional aspects of the action of indole-3-carbinol as antitumor agent // Ann. NY Acad. Sci. – 1999; 889: 204–13.
  31. Meng Q., Qi M. et al. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes // J. Mol. Med. – 2000; 78 (3): 155–65.
  32. Riby J., Chang G. et al. Ligand-independent activation of estrogen receptor function by 3-diindolylmethane in human breast cancer cells // Biochem. Pharmacol. – 2000; 60 (2): 167–77.
  33. Butterworth M., Lau S., Monks T. 17 β-esiradiol metabolism by hamster hepatic microsomes.Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens // Drug Metab. Dispos. – 1996; 24 (5): 588–94.
  34. Tully D., Allgood V., Cidlowski J. Modulation of steroid receptor-mediated gene expression by vitamin B6 // FASEB J. – 1994; 8 (3): 343–9.
  35. Bender D. Novel function of vitamin B6 // Proceedings Nutr. Soc. – 1994; 53: 625–30.
  36. Yoon K., Pellaroni L. et al. Differantial activation of wild-type and variant forms of estrogen receptor a by synthetic and natural estrogenic compounds using a promoter containing three estrogen- responsive elements // J. Steroid Biochem. Mol. Biol. – 2001; 78: 25–32.
  37. DeFlora S., Benniceli C., Camoiriano A. et al. In vivo effects of N-acetylcysteine on glutatione metabolism and on biotransformation of carcinogen and/or mutagenic compounds // Carcinogenesis. – 1985; 6: 1735–45.
  38. Wellington K., Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disordes // BioDrugs. – 2001; 15 (7): 465–89.
  39. Verma S., Goldin B., Lin P. The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids // Environ Health Perspect. – 1998; 106 (12): 807–12.
  40. Goud V., Polasa K., Krishnaswamy K. Effect of turmeric on xenobiotic metabolizing enzymes // Plant Foods Hum. Nutr. – 1993; 44 (1): 87–92.